New England Private Wealth Advisors LLC Merck & Co., Inc. Transaction History

New England Private Wealth Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$77.58 - $87.54 $786,661 - $887,655	-10,140 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $22,367 - $24,381	294 Added 2.99%	10,140 $854,000
Q2 2019 Aug 08, 2019	BUY	$69.84 - $81.59 $7,472 - $8,730	107 Added 1.1%	9,846 $828,000
Q1 2019 May 02, 2019	BUY	$69.58 - $79.36 $1,043 - $1,190	15 Added 0.15%	9,739 $809,000
Q4 2018 Feb 12, 2019	BUY	$65.24 - $75.71 $34,381 - $39,899	527 Added 5.73%	9,724 $742,000
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $28,441 - $33,445	-493 Reduced 5.09%	9,197 $650,000
Q2 2018 Aug 13, 2018	BUY	$50.83 - $59.72 $1,067 - $1,254	21 Added 0.22%	9,690 $592,000
Q1 2018 May 04, 2018	BUY	$50.96 - $59.23 $26,550 - $30,858	521 Added 5.7%	9,669 $526,000
Q4 2017 Feb 13, 2018	SELL	$51.62 - $61.64 $25,603 - $30,573	-496 Reduced 5.14%	9,148 $517,000
Q3 2017 Nov 09, 2017	BUY	$58.67 - $63.13 $565,813 - $608,825	9,644	9,644 $617,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of New England Private Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on New England Private Wealth Advisors LLC with notifications on news.